- Home
- AMED vs HCM Comparison
AMED vs HCM Comparison
Compare AMED & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMED
- HCM
- Stock Information
- Founded
- AMED 1982
- HCM 2000
- Country
- AMED United States
- HCM Hong Kong
- Employees
- AMED N/A
- HCM N/A
- Industry
- AMED Medical/Nursing Services
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- AMED Health Care
- HCM Health Care
- Exchange
- AMED Nasdaq
- HCM Nasdaq
- Market Cap
- AMED 2.8B
- HCM 2.3B
- IPO Year
- AMED N/A
- HCM N/A
- Fundamental
- Price
- AMED $92.80
- HCM $13.56
- Analyst Decision
- AMED Hold
- HCM Hold
- Analyst Count
- AMED 5
- HCM 1
- Target Price
- AMED $100.67
- HCM $19.00
- AVG Volume (30 Days)
- AMED 439.6K
- HCM 89.3K
- Earning Date
- AMED 02-19-2025
- HCM 02-26-2025
- Dividend Yield
- AMED N/A
- HCM N/A
- EPS Growth
- AMED 3058.49
- HCM N/A
- EPS
- AMED 2.52
- HCM N/A
- Revenue
- AMED $2,321,060,000.00
- HCM $610,806,000.00
- Revenue This Year
- AMED $7.09
- HCM N/A
- Revenue Next Year
- AMED $5.18
- HCM $18.76
- P/E Ratio
- AMED $36.83
- HCM N/A
- Revenue Growth
- AMED 4.19
- HCM N/A
- 52 Week Low
- AMED $82.15
- HCM $11.93
- 52 Week High
- AMED $98.95
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- AMED 70.47
- HCM 37.60
- Support Level
- AMED $91.81
- HCM $13.26
- Resistance Level
- AMED $92.64
- HCM $14.36
- Average True Range (ATR)
- AMED 0.71
- HCM 0.47
- MACD
- AMED 0.15
- HCM -0.02
- Stochastic Oscillator
- AMED 98.97
- HCM 17.61
About AMED Amedisys Inc
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.